ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

About this update from Ani Pharmaceuticals, Inc.

[{"type":"text","content":" BAUDETTE, Minn.--(BUSINESS WIRE)--\nANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows:\n\n\n\nH.C. Wainwright Global Investment Conference (Virtual)\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nDate:\n\n\n\nTuesday, May 24, 2022\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nTime:\n\n\n\nOn Demand, 7:00 a.m. ET\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nWebcast:\n\n\n\nClick Here\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nJefferies Healthcare Conference (New York City, NY)\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nDate:\n\n\n\nThursday, June 9, 2022\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nTime:\n\n\n\n11:30 a.m. ET\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nWebcast:\n\n\n\nClick Here\n\n\n\n\nThe webcasts will be accessible via the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.\n\nAbout ANI\n\nANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220520005082/en/\n\nInvestor Relations:\nLisa M. Wilson, In-Site Communications, Inc.\nT: 212-452-2793\nE: [email protected]\n\nSource: ANI Pharmaceuticals, Inc.","length":8249,"tagName":"div"}]

More updates from Ani Pharmaceuticals, Inc.